Checkpoint Inhibitors

Blocking DKK1 Reprograms Neutrophils and Revives Immunotherapy in Bone Metastases

Preclinical data showing that DKK1 inhibition revives checkpoint blockade efficacy against bone tumors have triggered clinical trials of DKN-01 guided by CHI3L3 biomarker research.